Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Fisher & Paykel Healthcare Corp. Ltd. (OTC: FSPKF).

Full DD Report for FSPKF

You must become a subscriber to view this report.


Recent News from (OTC: FSPKF)

Vapothem: Revenue Growth Of 18.16% Y/Y, But Upside Is Limited
Growth investors should appreciate Vapotherm, Inc. (VAPO). The company is growing revenues at 18.16% y/y, and its gross profit margin is large. VAPO does not seem undervalued at 5.11x sales, but it seems a name to be followed. Many institutional investors bought stock before the IPO. With th...
Source: SeekingAlpha
Date: November, 08 2018 15:30
Fisher & Paykel Healthcare Corp. Ltd (FSPKF) CEO Lewis Gradon on Q4 2018 Results - Earnings Call Transcript
Fisher & Paykel Healthcare Corp. Ltd (FSPKF) Q4 2018 Results Conference Call May 27, 2018 06:00 PM ET Executives Marcus Driller - General Manager Lewis Gradon - MD & CEO Paul Shearer - SVP of Sales and Marketing Tony Barclay - CFO Andrew Somervell - VP of Products and...
Source: SeekingAlpha
Date: May, 28 2018 15:05
Fisher & Paykel Healthcare reports FY results
Fisher & Paykel Healthcare ( OTCPK:FSPKF ): FY EPS of NZ$33.00 Revenue of NZ$980.8M (+9.7% Y/Y) Press Release More news on: Fisher & Paykel Healthcare Corp. Ltd., Earnings news and commentary, Healthcare stocks news,
Source: SeekingAlpha
Date: May, 28 2018 10:39
Inspire Medical Systems Finalizes IPO Terms
Quick Take Inspire Medical Systems ( INSP ) wants to raise $75 million in an IPO of its common stock. The company sells an implantable neurostimulation device to treat sleep apnea. INSP is growing topline revenues substantially, but financial results show only a gradual path to profi...
Source: SeekingAlpha
Date: April, 24 2018 13:13
Fisher & Paykel Healthcare's (FSPKF) CEO Lewis Gradon on Q2 2018 Results - Earnings Call Transcript
Fisher & Paykel Healthcare Corp. Ltd (FSPKF) Q2 2018 Earnings Conference Call November 20, 2017 04:00 PM ET Executives Marcus Driller - General Manager of Corporate Lewis Gradon - Managing Director & Chief Executive Officer Paul Shearer - Senior VP, Sales and Marketing ...
Source: SeekingAlpha
Date: November, 21 2017 15:31
Fisher & Paykel Healthcare Corp. Ltd. 2018 Q2 - Results - Earnings Call Slides
The following slide deck was published by Fisher & Paykel Healthcare Corp. Ltd. in conjunction with their 2018 Q2 earnings Read more ...
Source: SeekingAlpha
Date: November, 21 2017 12:49
Fisher & Paykel Healthcare (FSPKY) Investor Presentation - Slideshow
The following slide deck was published by Fisher & Paykel Healthcare Corp. Ltd. ADR in conjunction with this Read more ...
Source: SeekingAlpha
Date: October, 16 2017 14:00
ResMed's European patents infringed by Fisher & Paykel
ResMed (NYSE: RMD ) announces the following updates in its ongoing global patent infringement litigation with Fisher & Paykel ( OTCPK:FSPKF ): More news on: ResMed Inc., Fisher & Paykel Healthcare Corp. Ltd., Healthcare stocks news, Read more ...
Source: SeekingAlpha
Date: October, 06 2017 07:22

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-12-148.358.308.358.30400
2018-12-13N/A9.0295N/AN/A0
2018-12-12N/A9.0295N/AN/A0
2018-12-11N/A9.0295N/AN/A0
2018-12-10N/A9.0295N/AN/A0

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-12-1430040075.0000Short
2018-11-151,0801,080100.0000Short
2018-09-212,0002,61076.6284Short
2018-09-045050100.0000Short
2018-08-02100100100.0000Short

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on FSPKF.


About Fisher & Paykel Healthcare Corp. Ltd. (OTC: FSPKF)

Logo for Fisher & Paykel Healthcare Corp. Ltd. (OTC: FSPKF)

Fisher amp Paykel Healthcare is a leading designer, manufacturer and marketer of products and systems for use in respiratory care, acute care, and the treatment of obstructive sleep apnea.

 

Contact Information

 

 

Current Management

  • Michael A. Daniell / CEO
  • Antony A. Barclay / CFO, Secretary

Current Share Structure

  • Market Cap: $5,265,684,000 - 03/12/2018
  • Issue and Outstanding: 546,800,000 - 10/31/2013

 



Daily Technical Chart for (OTC: FSPKF)

Daily Technical Chart for (OTC: FSPKF)


Stay tuned for daily updates and more on (OTC: FSPKF)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (OTC: FSPKF)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in FSPKF is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of FSPKF and does not buy, sell, or trade any shares of FSPKF. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/